Compositions useful as contraceptives in males
CA 2059138 A1 · Owner: Applied Medical Research, Ltd. · Inventors: Cohen, Michael
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Abstract of the Disclosure, A method of effecting contraception in human males comprises administering a combination of melatonin and an androgenic hormone in a contraceptively effective amount. Optionally the, melatonin and androgenic hormone can be further combined with a progesterone. The administration of melatonin and androgenic hormone also provides a method of preventing prostate cancer in men.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 26, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 26, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 26, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.